Analytical Testing

Pharmaceutical Outsourcing Analytical Testing - Laptop Showing Data

Analytical testing services outsourcing allows pharmaceutical innovator companies to handle more complex tasks in-house while also assisting companies in concentrating on their core competencies, enabling pharmaceutical companies to avoid developing specialized facilities and hiring staff, results in cost savings.

Specifically, pharmaceutical analytical testing refers to quantifying and identifying components in pharmaceutical drugs and solutions. The goal is to ensure products meet FDA regulations for safety, potency, purity, and stability.

Analytical development and testing services may also include method development, method transfers, qualification and validation services.

Filter

Hide Filter

EAG Acquires PTRL West and PTRL Europe
Tuesday, April 10, 2012
Evans Analytical Group, Inc. (EAG), the world’s leading, fully integrated, independent laboratory network, providing high value expert analytical and testing services to a wide range of industries and end users, today announced that it has acquired ... read more
Clinical Trials Roundtable
Monday, March 26, 2012
Late phase clinical research has become a growing focus for regulators, CROs and biopharmaceutical and medical device companies. Increasing requirements for long-term safety and effectiveness of data collection during the peri-approval and post-... read more
Accelerated Stability Assessment Program (ASAP): Using Science to Set Shelf Life
Monday, March 26, 2012
Among the challenges involved in developing acceptable commercial dosage forms for active pharmaceutical ingredients (API’s) is demonstrating adequate chemical stability [1,2]. Expiration dating is generally determined based on the time a drug ... read more
Tactical Versus Strategic Outsourcing: Are the Drivers the Same for Large, Medium, and Small Sponsor Companies?
Monday, March 26, 2012
In any venue where clinical development outsourcing is being discussed, sooner or later someone always seems to wonder aloud if small companies can get the same attention from their providers that large companies do. What’s intriguing about this ... read more
Aptuit LLC Names Stuart E. Needleman as President and Chief Operating Officer
Thursday, March 15, 2012
Greenwich, CT, March 15, 2012 - Timothy C. Tyson, Aptuit Chairman, announced that effective immediately, Stuart E. Needleman has been named President and Chief Operating Officer of Aptuit LLC. Following the recent sale of the company’s Clinical ... read more
Using Advanced Drug Development Technologies For Better Treatments
Thursday, March 15, 2012
Somerset, NJ – March 15, 2012 – Catalent Pharma Solutions, a leading global industry partner in product development, delivery and supply has extensive expertise in bringing more products to more markets around the world and will present a series of ... read more
INC Research to Discuss Global Partnerships and Future Trends
Tuesday, February 28, 2012
INC Research, LLC, a therapeutically focused clinical research organization (CRO) with a Trusted Process® for delivering reliable results, will discuss the evolution of clinical development outsourcing trends at the Partnerships(TM) in Clinical ... read more
ICON Acquires PriceSpective
Tuesday, February 28, 2012
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of PriceSpective LLC, a global leader in value strategy consulting. The acquisition ... read more
Boehringer Ingelheim and Xencor Enter a Collaboration Agreement
Tuesday, February 21, 2012
Xencor, Inc., a company using its proprietary Protein Design Automation® (PDA) platform technology to engineer next-generation antibodies, and Boehringer Ingelheim announced today a collaboration agreement for certain Xencor biosuperior monoclonal ... read more
Catalent Completes Acquisition of Clinical Trials Supplies Business of Aptuit LLC
Friday, February 17, 2012
Catalent Pharma Solutions today announced that it has completed the acquisition of the Clinical Trial Supplies business of Aptuit LLC. The acquisition substantially expands Catalent’s Development & Clinical Services business, transforming it into the... read more
Ockham Completes Acquisition of Nexus Oncology
Thursday, February 16, 2012
Ockham, a leading, global full-service contract research organization (CRO) with a focus in oncology, today announces it has completed the acquisition of Nexus Oncology. The transaction also provides Ockham with an institutional investment partner. read more
One Year On…Almac Doubles Analytical Capacity in US Headquarters
Thursday, February 09, 2012
Almac is pleased to announce the doubling of analytical capacity at its 240,000 sq. ft. North American Headquarters. The facility, built on a 40 acre site in Souderton, PA, north of Philadelphia, and occupied since 2010, delivers full-service, ... read more
INC Research Releases New White Paper
Wednesday, February 08, 2012
INC Research , LLC, a therapeutically focused clinical research organization (CRO) with a trusted process for delivering reliable results, today announced it has released a new white paper titled, "The Innovation Imperative: How CROs Are Driving The... read more
Analytical Testing Roundtable
Sunday, January 01, 2012
DN: In my experience, the single most significant trend in pharmaceutical outsourcing in general, and analytical testing in particular, is the emergence of so-called “preferred vendors”. In the early 1990s there were only a few contract research ... read more
Forced Degradation to Develop Stability-indicating Methods
Sunday, January 01, 2012
Forced Degradation (or stress testing) typically involves exposure of drug substances to heat, heat and humidity and light for solid-state studies. For solution-state studies the drug substance is exposed to a range of pH values. The experimental ... read more